NCT02851186

Brief Summary

Objectives: To examine the efficacy and safety of electroacupuncture (EA) combined with auricular acupuncture (AA) in reducing post-operative pain in patients following abdominal surgery for gynecological diseases. Hypothesis: Acupuncture is effective and safe to reduce postoperative pain during the first 5 days following surgery as compared to a sham control. Design and strategy: This is a randomized, placebo-controlled, subject- and assessor-blind trial. Seventy-two subjects will be recruited and randomized (in 1:1 ratio) to receive either acupuncture treatment or sham control. Subjects in both groups will undergo standard operation procedure and receive post-operative analgesics based on usual care. Study instrument: A 10-point pain Numerical Rating Scale (NRS) will be employed as a primary outcome assessment. Intervention: Subjects in the treatment group will receive EA combined with AA within two hours before operation, post-operation upon arrival to the ward and once a day for the subsequent 5 days. Subjects in the control group will receive non-invasive sham procedure in the same schedule. Main outcome measures: Primary outcome: NRS pain scores will be measured upon recovery, hourly at 6 hours after surgery, then 4-hourly until day 2, 6-hourly until day 3 and once daily until discharge. Secondary outcome: Morphine consumption, post-operative syndromes, quality of recovery questionnaire, SF-6D, EQ-5D-5L and adverse events will be documented and compared between groups. Data analysis: Pain intensity during the first 5 days will be calculated by Area Under the Curve (AUC) of NRS pain scores. AUC between the two groups will be compared by Student's T-test. Expected outcome: AUC of the acupuncture group is expected to be significantly lower than sham acupuncture group.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
72

participants targeted

Target at P50-P75 for not_applicable postoperative-pain

Timeline
Completed

Started Oct 2016

Longer than P75 for not_applicable postoperative-pain

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 19, 2016

Completed
13 days until next milestone

First Posted

Study publicly available on registry

August 1, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

October 12, 2016

Completed
2.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2018

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 1, 2018

Completed
Last Updated

September 17, 2019

Status Verified

September 1, 2019

Enrollment Period

2.1 years

First QC Date

July 19, 2016

Last Update Submit

September 13, 2019

Conditions

Outcome Measures

Primary Outcomes (1)

  • Area under the curve of Pain intensity by numerical rating scale (NRS) from baseline to day 5

    5 days

Secondary Outcomes (9)

  • Pain intensity by numerical rating scale (NRS) at rest

    Through study completion, an average of 7 days

  • Pain intensity by numerical rating scale (NRS) while coughing

    Through study completion, an average of 7 days

  • Cumulative morphine consumption

    Through study completion, an average of 7 days

  • Dose of rescues analgesic (IM morphine) use

    Through study completion, an average of 7 days

  • Frequency of rescues analgesic (IM morphine) use

    Through study completion, an average of 7 days

  • +4 more secondary outcomes

Other Outcomes (5)

  • Number of patients withdraw

    Through study completion, an average of 7 days

  • Reasons of withdrawal

    Through study completion, an average of 7 days

  • Number of subjects with adverse events

    Through study completion, an average of 7 days

  • +2 more other outcomes

Study Arms (2)

Electroacupuncture (EA) and Auricular Acupuncture (AA)

EXPERIMENTAL

Subjects in the treatment group will receive EA combined with AA two hours before operation, immediately post-operation and once a day for the subsequent 5 days.

Device: Acupuncture

Sham acupuncture

SHAM COMPARATOR

Subjects in the control group will receive non-invasive sham procedure in the same schedule as the treatment group.

Device: Sham acupuncture

Interventions

Electroacupuncture (EA) and Auricular Acupuncture (AA)
Sham acupuncture

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • American Society of Anesthesiologists (ASA) physical status I to III
  • Eligible for laparotomy with midline incision for gynaecological neoplasm including ovarian mass, uterine mass and cervical lesions
  • Age 18 years or above
  • Ability to understand the nature of the study and willing to give informed consent
  • Capable of providing responses during outcome measurement

You may not qualify if:

  • Having chronic pain and using any medication in addition to the anaesthetic and analgesia prescribed prior to surgery that would be expected to affect the dosage of postoperative analgesia
  • History of or current alcohol or drug abuse
  • Impaired renal function, defined as preoperative serum creatinine level over 120µmol/L
  • Impaired hepatic function, defined as preoperative serum albumin level below 30g/L
  • Impaired or retarded mental state and not able to sign the consent
  • Not self-ambulatory before operation
  • Difficulties in using patient-controlled analgesia
  • BMI \> 35kg/m2
  • Infection observed at the acupoint sites
  • History of acupuncture experience in the previous 12 months
  • History or clinical evidence of valvular heart defects, heart failure, atrial fibrillation or bleeding disorders or are fitted with cardiac pacemaker or taking anticoagulant drugs

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Kwong Wah Hospital

Hong Kong, Hong Kong

Location

Queen Mary Hospital

Hong Kong, Hong Kong

Location

Related Publications (1)

  • Lam WL, Yeung WF, Wong MK, Cheung CW, Chan KKL, Ngan HYS, Wong CKH, Chen HY, Lao L. Combined electroacupuncture and auricular acupuncture for postoperative pain after abdominal surgery for gynecological diseases: study protocol for a randomized controlled trial. Trials. 2018 Jan 4;19(1):8. doi: 10.1186/s13063-017-2359-8.

MeSH Terms

Conditions

Pain, Postoperative

Interventions

Acupuncture Therapy

Condition Hierarchy (Ancestors)

Postoperative ComplicationsPathologic ProcessesPathological Conditions, Signs and SymptomsPainNeurologic ManifestationsSigns and Symptoms

Intervention Hierarchy (Ancestors)

Complementary TherapiesTherapeutics

Study Officials

  • Lixing LAO

    The University of Hong Kong

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 19, 2016

First Posted

August 1, 2016

Study Start

October 12, 2016

Primary Completion

November 1, 2018

Study Completion

November 1, 2018

Last Updated

September 17, 2019

Record last verified: 2019-09

Locations